Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study

PURPOSE: The primary purpose of this study was to evaluate the proportion of psoriatic arthritis (PsA) patients maintaining clinical remission after adalimumab (ADA) dose reduction compared with patients with rheumatoid arthritis. Secondary purposes include evaluating the proportion of PsA patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantini, Fabrizio, Niccoli, Laura, Cassarà, Emanuele, Kaloudi, Olga, Nannini, Carlotta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421476/
https://www.ncbi.nlm.nih.gov/pubmed/22904612
http://dx.doi.org/10.2147/BTT.S31145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421476/
https://www.ncbi.nlm.nih.gov/pubmed/22904612
http://dx.doi.org/10.2147/BTT.S31145

Ejemplares similares